Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers January 23, 2017
Pharmacy Choice - News - U.S. Pharmaceutical Industry - January 23, 2017

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

1/23/17 - "Pharmaceutical Composition with Improved Bioavailability" in Patent Application Approval Process (USPTO 20170000764)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Lomuscio, Steve; Ma, Hua; Matchett, Michael Allen; Sandhu, Harpreet K.; Shah, Navnit Hargovindas; Zhang, Yu-E, filed on July 1, 2016, was made available online on January 12, 2017, according to news reporting originating from Washington, D.C., by Ne
1/23/17 - "Small Rna, Preparation Method Therefor and Application Thereof in Pharmaceuticals for Specifically Up-Regulating Gene Transcriptional Activity" in...
"Small Rna, Preparation Method Therefor and Application Thereof in Pharmaceuticals for Specifically Up-Regulating Gene Transcriptional Activity" in Patent Application Approval Process. By a News Reporter-Staff News Editor at AIDS Weekly A patent application by the inventors Zhang, Hui; Zhang, Yijun, filed on October 9, 2013, was made available on
1/23/17 - "System and Method for Pharmacovigilance" in Patent Application Approval Process (USPTO 20170004274)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors MEHTA, Rajesh Revachand; WEI, Henry George; STEINBERG, Gregory Brian, filed on August 30, 2016, was made available online on January 12, 2017, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appli
1/23/17 - A web of illegal pharma drugs [Mail Today (India)]
This unregulated trade has taken a firm root in India as a supplier and had lured many peddlers into this business after tying a knot with pharmacies. In 2016, more than 500 kg of tablets have been seized by the Narcotics Control Bureau that were suspected of being sent to USA and Europe. The emergence of illegal websites is another concern for the
1/23/17 - Abbott Laboratories Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Jan. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on January 6, 2017. The SEC file number is 0001104659-17-001245.. A U.S. Securities and Exchange Commission filing is
1/23/17 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jan. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on January 6, 2017. The SEC file number is 0001104659-17-001247.. A U.S. Securities and Exchange Commission filing is
1/23/17 - Abbott Laboratories Files SEC Form 8-K, Current Report (Jan. 5, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on January 5, 2017. The SEC file number is 0001104659-17-000934.. A U.S. Securities and Exchange Commission filing is
1/23/17 - Acceleron Pharma Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jan. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on January 6, 2017. The SEC file number is 0001179110-17-000680.. A U.S. Securities and Exchange Commission filing i
1/23/17 - Acceleron Pharma Inc. Files SEC Form 8-K, Current Report (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acceleron Pharma Inc. was posted on January 9, 2017. The SEC file number is 0001280600-17-000002.. A U.S. Securities and Exchange Commission filing i
1/23/17 - AcelRx Pharmaceuticals Announces DSUVIA as Brand Name for ARX-04 in the United States
By a News Reporter-Staff News Editor at Pharma Business Week- AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain, announced that the U.S. Food and Drug Administration has conditionally accepted the brand name,.
1/23/17 - Acelrx Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acelrx Pharmaceuticals Inc. was posted on January 9, 2017. The SEC file number is 0001437749-17-000345.. A U.S. Securities and Exchange Commission fi
1/23/17 - Achaogen Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Jan. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Achaogen Inc. was posted on January 6, 2017. The SEC file number is 0001140361-17-001065.. A U.S. Securities and Exchange Commission filing is a form
1/23/17 - Achaogen Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jan. 6, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Achaogen Inc. was posted on January 6, 2017. The SEC file number is 0001140361-17-001066.. A U.S. Securities and Exchange Commission filing is a form
1/23/17 - Achaogen Inc. Files SEC Form 8-K, Current Report (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Achaogen Inc. was posted on January 9, 2017. The SEC file number is 0001301501-17-000002.. A U.S. Securities and Exchange Commission filing is a form
1/23/17 - Acura Pharmaceuticals, Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jan. 5, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on January 5, 2017. The SEC file number is 0001209191-17-001963.. A U.S. Securities and Exchange Commission fi
1/23/17 - Acura Pharmaceuticals, Inc. Files SEC Form SC 13G/A, Statement of Acquisition of Beneficial Ownership By Individuals (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acura Pharmaceuticals, Inc. was posted on January 9, 2017. The SEC file number is 0001535610-17-000023.. A U.S. Securities and Exchange Commission fi
1/23/17 - Aeterna Zentaris Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16] (Jan. 5, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on January 5, 2017. The SEC file number is 0001104659-17-000849.. A U.S. Securities and Exchange Commission filing i
1/23/17 - Aeterna Zentaris Inc. Files SEC Form SC 13G/A, Statement of Acquisition of Beneficial Ownership By Individuals (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Aeterna Zentaris Inc. was posted on January 9, 2017. The SEC file number is 0001535610-17-000029.. A U.S. Securities and Exchange Commission filing i
1/23/17 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Premarket Approval of Medical...
All comments should be identified with the OMB control number 0910-0231. Also include the FDA docket number found in brackets in the heading of this document. SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance. Under section 515 of the Fede
1/23/17 - Agile Therapeutics Inc. Files SEC Form 8-K, Current Report (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agile Therapeutics Inc. was posted on January 9, 2017. The SEC file number is 0001104659-17-001365.. A U.S. Securities and Exchange Commission filing
1/23/17 - Agios Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agios Pharmaceuticals Inc. was posted on January 9, 2017. The SEC file number is 0001193125-17-005152.. A U.S. Securities and Exchange Commission fil
1/23/17 - Agios Pharmaceuticals Inc. Files SEC Form SC 13G/A, Statement of Acquisition of Beneficial Ownership By Individuals (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Agios Pharmaceuticals Inc. was posted on January 9, 2017. The SEC file number is 0001562230-17-000001.. A U.S. Securities and Exchange Commission fil
1/23/17 - Alexion Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Jan. 9, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on January 9, 2017. The SEC file number is 0000899866-17-000007.. A U.S. Securities and Exchange Commission f
1/23/17 - Alexion Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Jan. 5, 2017)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Alexion Pharmaceuticals Inc. was posted on January 5, 2017. The SEC file number is 0000899866-17-000004.. A U.S. Securities and Exchange Commission f
1/23/17 - Allergan's Trademark Application for "TNS ILLUMINATING EYE CREAM" Filed
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TNS ILLUMINATING EYE CREAM" by Susan J. Hinchey, representing Allergan. The owner/registrar information for this application is: Susan J. Hinchey, Allergan, 2
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415